Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma
Myriam Sasanelli, Michel Meignan, Corinne Haioun, Alina Berriolo-Riedinger, René Olivier Casasnovas, Alberto Biggi, Andrea Gallamini, Barry A. Siegel, Amanda F. Cashen, Pierre Véra, Hervé Tilly, Annibale Versari, Emmanuel Itti
Dive into the research topics of 'Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma'. Together they form a unique fingerprint.